SEC Form 4 · accession 0001209191-18-058568
EXACT SCIENCES CORP · EXAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katherine S Zanotti
Director
Period of report
Nov 12, 2018
Accepted (ET)
Nov 14, 2018 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124140
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 31, 2018 | G | 3,411 | $0.00 | D | 102,786 | D | |
| Common Stock | Oct 31, 2018 | G | 684 | $0.00 | D | 102,102 | D | |
| Common StockF1 | Nov 12, 2018 | M | 7,667 | $3.43 | A | 109,769 | D | |
| Common StockF2 | Nov 12, 2018 | S | 7,667 | $69.00 | D | 102,102 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.43 | Nov 12, 2018 | M | 7,667 | D | Jul 16, 2011 | Jul 16, 2020 | Common Stock | 7,667 | 0 | D |
Explanation of responses
- F1Represents shares of common stock received upon exercise of a stock option award.
- F2The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan.